期刊文献+

A Novel Pharmacophore Model Derived from a Class of Capsid Protein Enterovirus 71 Inhibitors

A Novel Pharmacophore Model Derived from a Class of Capsid Protein Enterovirus 71 Inhibitors
下载PDF
导出
摘要 Capsid protein enterovirus 71 (EV71) is one of the major viruses that cause the severe encephalitis and thus result in a high mortality in children less than 5 years of age.In an effort to discover new potent inhibitors against EV71,a novel three-dimensional pharmacophore model was developed on 24 inhibitors with different molecular structures and bioactivities.The best hypothesis (Hypo1) has a high predictive power and consists of four features,namely,one hydrophobic point (HY) and three hydrogen-bond acceptors (HA).Two key features of the best Hypo1,HY1 and HA3 match well with an important narrow hydrophobic canyon and with the surface of LYS274 in the target EV71 active site,respectively.The more versatile feature,HA1,is firstly found to be very influential on these compounds’ bioactivities,which may interact with the other side of the active site in the EV71 receptor.The application of the model is successful in predicting the activities of 30 known EV71 inhibitors with a correlation coefficient of 0.831.Furthermore,Hypo1 demonstrates a superior screening capability for retrieving inhibitors from the database with a high enrichment factor of 70.This study provides some important clues in search for more potent inhibitors against EV71 infection. Capsid protein enterovirus 71 (EV71) is one of the major viruses that cause the severe encephalitis and thus result in a high mortality in children less than 5 years of age.In an effort to discover new potent inhibitors against EV71,a novel three-dimensional pharmacophore model was developed on 24 inhibitors with different molecular structures and bioactivities.The best hypothesis (Hypo1) has a high predictive power and consists of four features,namely,one hydrophobic point (HY) and three hydrogen-bond acceptors (HA).Two key features of the best Hypo1,HY1 and HA3 match well with an important narrow hydrophobic canyon and with the surface of LYS274 in the target EV71 active site,respectively.The more versatile feature,HA1,is firstly found to be very influential on these compounds’ bioactivities,which may interact with the other side of the active site in the EV71 receptor.The application of the model is successful in predicting the activities of 30 known EV71 inhibitors with a correlation coefficient of 0.831.Furthermore,Hypo1 demonstrates a superior screening capability for retrieving inhibitors from the database with a high enrichment factor of 70.This study provides some important clues in search for more potent inhibitors against EV71 infection.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2012年第8期1159-1169,共11页 结构化学(英文)
基金 Sponsored by the National Natural Science Foundation of China (No. 30800719)
关键词 capsid protein enterovirus 71 inhibitor hand-foot-and-mouth disease pharmacophore model hydrogen-bond acceptor hydrophobic point capsid protein enterovirus 71 inhibitor; hand-foot-and-mouth disease; pharmacophore model; hydrogen-bond acceptor; hydrophobic point
  • 相关文献

参考文献33

  • 1Schmidt, N. J.; Lennette, E. H.; Ho, H. H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974, 129, 304-309.
  • 2Gomes, M. L.; de Castro, C. M.; Oliveira, M. J.; da Silva, E. E. Neutralizing antibodies to enterovirus 7l in Belom, Brazil. Inst. Oswaldo Cruz. 2002, 97, 47-49.
  • 3Ooi, E. E.; Phoon, M. C.; Lshak, B.; Chan, S. H. Seroepidemiology of human enterovirus 71, Singapore. Emerg. Infect. Dis. 2002, 8, 995-997.
  • 4Chang, L. Y; Lin, T. Y.; Hsu, K. H.; Huang, Y. C.; Lin, K. L.; Hsueh, C.; Shih, S. R.; Ning, H. C.; Hwang, M. S., Wang, H. S.; Lee, C. Y. Clinical features and risk factors of pulmonary edema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999, 354, 1682-1686.
  • 5Lum, L. C.; Wong, K. T.; Lam, S. K.; Chua, K. B.; Goh, A. Y.; Lim, W. L.; Ong, B. B.; Paul, G; AbuBakar, S.; Lambert, M. Fatal enterovirus 71 encephalomyelitis. J. Pediatr 1998, 133, 795-798.
  • 6Yan, J. J.; Wang, J. R.; Liu, C. C.; Yang, H. B.; Su, I. J. An outbreak of enterovirus 71 infection in Taiwan 1998-a comprehensive pathological, virological and molecular study on a case of fulminant encephalitis. J. Clin. Virol. 2000, 17, 13-22.
  • 7Ishimaru, Y; Nakano, S.; Yamaoka, K.; Takami, S. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch. Dis. Child 1980, 55,583-588.
  • 8Liu, C. C.; Tseng, H. W.; Wang, S. M.; Wang, J. R.; Su, I. J. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic arid clinical manifestations. J. Clin. Virol. 2000, 17, 23-30.
  • 9Lu, C. Y.; Lee, C. Y.; Kao, C. L.; Shao, W. Y.; Lee, P. I.; Twu, S. J.; Yeh, C. C.; Lin, S. C.; Shih, W. Y.; Wu, S. L.; Huang, L. M. Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan..Z. Med. Virol. 2002, 67, 217-223.
  • 10Lin, T. Y.; Twu, S. J.; Ho, M. S.; Chang, L. Y; Lee, C. Y. Enterovirus 71 out breaks, Taiwan: occurrence and reloghition. Emerg. Infect. Dis. 2003, 9, 291-293.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部